Case Reports

Treatment strategies for progressive immune effector cell-associated hemophagocytic lymphohistiocytosis-like syndrome: case series

Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford Cancer Institute, Stanford University, School of Medicine, Stanford, CA
Pediatric Stem Cell Transplant and Cellular Therapy, Atrium Health Levine Children’s Hospital, Charlotte, NC
Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD
Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD
Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford Cancer Institute, Stanford University, School of Medicine, Stanford, CA
Division of Pediatric Oncology and Surgery, Department of Women’s and Children’s Health, Karolinska Institute, and Department of Paediatric Oncology, Astrid Lindgren Children’s Hospital, Karolinska University Hospital, Stockholm, Sweden
Pediatric Stem Cell Transplant and Cellular Therapy, Atrium Health Levine Children’s Hospital, Charlotte, NC
Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford Cancer Institute, Stanford University, School of Medicine, Stanford, CA
Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
Vol. 109 No. 10 (2024): October, 2024 https://doi.org/10.3324/haematol.2023.284784